Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
TMCnet.com,
] Pfizer Inc. (NYSE:PFE) announced that three abstracts for XELJANZ ® (tofacitinib citrate), being investigated in moderate to…
] Pfizer Inc. (NYSE:PFE) announced that three abstracts for XELJANZ ® (tofacitinib citrate), being investigated in moderate to…
Pfizer to Present New Data on XELJANZ ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016 Pfizer Inc.
Pfizer to Present New Data on XELJANZ ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016 NEW YORK — (BUSINESS WIRE…
NEW YORK --(BUSINESS WIRE) Pfizer Inc. (NYSE:PFE) announced that three abstracts for XELJANZ® (tofacitinib citrate), being…